• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Goldman Sachs initiated coverage on Omega Therapeutics with a new price target

    8/24/21 5:03:16 AM ET
    $OMGA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $OMGA alert in real time by email
    Goldman Sachs initiated coverage of Omega Therapeutics with a rating of Neutral and set a new price target of $22.00
    Get the next $OMGA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OMGA

    DatePrice TargetRatingAnalyst
    11/15/2024Outperform → Mkt Perform
    Raymond James
    6/18/2024$12.00Outperform
    Raymond James
    5/25/2023$18.00 → $15.00Buy
    Jefferies
    12/8/2022$11.00Buy
    H.C. Wainwright
    9/23/2022$12.00Buy
    Chardan Capital Markets
    8/24/2021$36.00Outperform
    Wedbush
    8/24/2021$30.00Buy
    Jefferies
    8/24/2021$30.00Overweight
    Piper Sandler
    More analyst ratings

    $OMGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Varsalone Jeffrey T

      3 - Omega Therapeutics, Inc. (0001850838) (Issuer)

      2/4/25 9:59:03 PM ET
      $OMGA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director Mehrotra Ravi

      4 - Omega Therapeutics, Inc. (0001850838) (Issuer)

      12/5/24 4:10:05 PM ET
      $OMGA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 3 filed by new insider Mehrotra Ravi

      3 - Omega Therapeutics, Inc. (0001850838) (Issuer)

      12/5/24 4:05:05 PM ET
      $OMGA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care